RAINBOW, paclitaxel + ramucirumab:
Wilke H.
Lancet Oncol
2014; 15
:
1224–35.
REGARD, ramucirumab
: Fuchs C, for the REGARD Trial Investigators.
Lancet
2014; 383: 31–39.
2ªL: dianas y fármacos